Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 18/12/20131 min de lectura
Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) (the Agencies) are announcing the extension of the "Pilot Program for Parallel Review of Medical Products." The Agencies have decided to continue the program as currently designed for an additional period of 2 years from the date of publication of this notice.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →